Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2002 4(1):9-21; DOI:10.1215/15228517-4-1-9
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hussaini, I. M.
Right arrow Articles by VandenBerg, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Basic and Translational Investigations

Protein kinase C-{eta} regulates resistance to UV- and {gamma}-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation

Isa M. Hussaini2, Joan E. Carpenter, Gerard T. Redpath, Julianne J. Sando, Mark E. Shaffrey and Scott R. VandenBerg

Departments of Pathology (Neuropathology) (I.M.H., J.E.C., G.T.R., S.R.V.), Anesthesiology (J.J.S.), and Neurosurgery (M.E.S.), University of Virginia, Charlottesville, VA 22908

2 Address correspondence and reprints requests to Isa M. Hussaini, Dept. of Pathology (Neuropathology), The University of Virginia, Charlottesville, VA 22908.

Both increased cell proliferation and apoptosis play important roles in the malignant growth of glioblastomas. We have demonstrated recently that the differential expression of protein kinase C (PKC)-{eta} increases the proliferative capacity of glioblastoma cells in culture; however, specific functions for this novel PKC isozyme in the regulation of apoptosis in these tumors has not been defined. In the present study of several glioblastoma cell lines, we investigated the role of PKC-{eta} in preventing UV- and {gamma}-irradiation-induced apoptosis and in caspase-dependent signaling pathways that mediate cell death. Exposure to UV or {gamma} irradiation killed 80% to 100% of PKC-{eta}-deficient nonneoplastic human astrocytes and U-1242 MG cells, but had little effect on the PKC-{eta}-expressing U-251 MG and U-373 MG cells. PKC-{eta} appears to mediate resistance to irradiation specifically such that when PKC-{eta}h was stably expressed in U-1242 MG cells, more than 80% of these cells developed resistance to irradiation-induced apoptosis. Reducing PKC-{eta} expression by transient and stable expression of antisense PKC-{eta} in wild-type U-251 MG cells results in increased sensitivity to UV irradiation in a fashion similar to U-1242 MG cells and nonneoplastic astrocytes. Irradiation of PKC-{eta}-deficient glioblastoma cells resulted in the activation of caspase-9 and caspase-3, cleavage of poly (ADP-ribose) polymerase (PARP), and a substantial increase in subdiploid DNA content that did not occur in PKC-{eta}-expressing tumor cells. A specific inhibitor (Ac-DEVD-CHO) of caspase-3 blocked apoptosis in PKC-{eta}-deficient U-1242 MG cells. The data demonstrate that resistance to UV and {gamma} irradiation in glioblastoma cell lines is modified significantly by PKC-{eta} expression and that PKC-{eta} appears to block the apoptotic cascade at caspase-9 activation.




This article has been cited by other articles:


Home page
Neuro OncolHome page
M. Entin-Meer, X. Yang, S. R. VandenBerg, K. R. Lamborn, A. Nudelman, A. Rephaeli, and D. A. Haas-Kogan
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas
Neuro-oncol, April 1, 2007; 9(2): 82 - 88.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Sonnemann, V. Gekeler, A. Sagrauske, C. Muller, H.-P. Hofmann, and J. F. Beck
Down-regulation of protein kinase C{eta} potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 773 - 781.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2002 by Society for Neuro-Oncology